Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/35407
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Buising K. | en |
dc.contributor.author | Dowson L. | en |
dc.contributor.author | Bennett N. | en |
dc.contributor.author | Marshall C. | en |
dc.contributor.author | Kong D.C.M. | en |
dc.contributor.author | Stuart R.L. | en |
dc.contributor.author | Friedman N.D. | en |
dc.date.accessioned | 2021-05-14T11:57:45Z | en |
dc.date.available | 2021-05-14T11:57:45Z | en |
dc.date.copyright | 2020 | en |
dc.date.created | 20200304 | en |
dc.date.issued | 2020-03-04 | en |
dc.identifier.citation | American Journal of Infection Control. 48 (3) (pp 261-266), 2020. Date of Publication: March 2020. | en |
dc.identifier.issn | 0196-6553 | en |
dc.identifier.uri | https://repository.monashhealth.org/monashhealthjspui/handle/1/35407 | en |
dc.description.abstract | Background: Since 2015 the Aged Care National Antimicrobial Prescribing Survey has collected and reported data on antibiotic use in Australian aged care homes (ACHs) as part of the Australian Commission on Safety and Quality in Health Care's Antimicrobial Use and Resistance in Australia project. The objective of this study was to analyze this data source with regards to prescribing for urinary tract infections (UTIs) to improve the use of antibiotics. Method(s): This cross-sectional study analyzed the 2016 and 2017 survey data. Antibiotic prescribing for urinary tract indications was compared with national guideline recommendations. Result(s): A total of 662 antibiotic prescriptions from 247 ACHs were analyzed. For all prophylactic antibiotics for UTI, 51.8% were prescribed for longer than 6 months, contrary to the guideline recommendation. Most antibiotics prescribed for treatment (71.6%) were for cystitis. Cefalexin was most frequently selected for treatment of cystitis, with 10.4% of these prescriptions being concordant with the recommendations. Prescribing additional daily doses of cefalexin occurred in 63.2% of prescriptions. Conclusion(s): Antimicrobial stewardship activities targeting UTI prophylaxis for durations longer than 6 months, and excessive daily doses of cefalexin to treat cystitis could yield significant reductions in unnecessary antibiotic consumption among Australian residents of ACHs.Copyright © 2019 | en |
dc.language | English | en |
dc.language | en | en |
dc.publisher | Mosby Inc. (E-mail: customerservice@mosby.com) | en |
dc.relation.ispartof | American Journal of Infection Control | en |
dc.subject.mesh | gentamicin | - |
dc.subject.mesh | prescription | - |
dc.subject.mesh | treatment indication | - |
dc.subject.mesh | urinary tract infection | - |
dc.subject.mesh | amoxicillin plus clavulanic acid | - |
dc.subject.mesh | antibiotic agent | - |
dc.subject.mesh | cefalexin | - |
dc.subject.mesh | cefalotin | - |
dc.subject.mesh | ceftriaxone | - |
dc.subject.mesh | ciprofloxacin | - |
dc.subject.mesh | clarithromycin | - |
dc.subject.mesh | clindamycin | - |
dc.subject.mesh | cotrimoxazole | - |
dc.subject.mesh | doxycycline | - |
dc.subject.mesh | gentamicin | - |
dc.subject.mesh | nitrofurantoin | - |
dc.subject.mesh | norfloxacin | - |
dc.subject.mesh | trimethoprim | - |
dc.subject.mesh | aged | - |
dc.subject.mesh | antibiotic therapy | - |
dc.subject.mesh | antimicrobial stewardship | - |
dc.subject.mesh | Australian | - |
dc.subject.mesh | bedtime dosage | - |
dc.subject.mesh | cystitis | - |
dc.subject.mesh | drug use | - |
dc.subject.mesh | home for the aged | - |
dc.subject.mesh | practice guideline | - |
dc.title | Urinary tract infections in Australian aged care homes: Antibiotic prescribing practices and concordance to national guidelines. | en |
dc.type | Article | en |
dc.identifier.affiliation | Infectious Diseases and Clinical Microbiology | - |
dc.identifier.affiliation | Infection Prevention and Epidemiology | - |
dc.type.studyortrial | Observational study (cohort, case-control, cross sectional or survey) | - |
dc.identifier.doi | http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1016/j.ajic.2019.08.034 | - |
dc.publisher.place | United States | en |
dc.identifier.pubmedid | 31677924 [http://www.ncbi.nlm.nih.gov/pubmed/?term=31677924] | en |
dc.identifier.source | 2003567613 | en |
dc.identifier.institution | (Dowson, Bennett, Buising, Marshall, Friedman, Stuart, Kong) National Centre for Antimicrobial Stewardship at The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia (Dowson, Kong) Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia (Bennett) Victorian Healthcare Associated Infection Surveillance System Coordinating Centre at, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia (Bennett) Department of Nursing, Melbourne School of Health Sciences, The University of Melbourne, Carlton, Victoria, Australia (Buising, Marshall) Victorian Infectious Diseases Service at, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia (Buising, Marshall) Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia (Marshall) Infection Prevention and Surveillance Service, The Royal Melbourne Hospital, Parkville, Victoria, Australia (Friedman) School of Medicine, Deakin University, Geelong, Victoria, Australia (Friedman) Department of General Medicine and Department of Infectious Diseases, Barwon Health, Geelong, Victoria, Australia (Stuart) Department of Medicine, School of Clinical Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia (Stuart) Monash Infectious Diseases and Infection Control and Epidemiology, Monash Health, Clayton, Victoria, Australia (Kong) Pharmacy Department, Ballarat Health Services, Ballarat, Victoria, Australia | en |
dc.description.address | N. Bennett, VICNISS Coordinating Centre at The Peter Doherty Institute for Infection and Immunity, 792 Elizabeth St, Melbourne 3000, Australia. E-mail: noleen.bennett@mh.org.au | en |
dc.description.publicationstatus | Embase | en |
dc.rights.statement | Copyright 2020 Elsevier B.V., All rights reserved. | en |
dc.subect.keywords | Anti-infective agents Antibacterial agents Cystitis Long-term care Nursing home | en |
dc.identifier.authoremail | Bennett N.; noleen.bennett@mh.org.au | en |
item.cerifentitytype | Publications | - |
item.fulltext | No Fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.grantfulltext | none | - |
item.openairetype | Article | - |
crisitem.author.dept | Infection Prevention and Epidemiology | - |
Appears in Collections: | Articles |
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.